Les Meilleurs doctors pour le traitement d'anémie aplastique en Israël - TOP-18 des médecins

Les informations sur le médecin sont en cours de mise à jour. Le Dr Ron exerce au centre médical Sourasky (Ichilov).

Le Dr Ram a réalisé plusieurs centaines de greffes de cellules souches – un traitement clé pour l'anémie aplasique – au centre médical Sourasky.

• Certifié en hématologie et en oncologie médicale
• Formation spécialisée (Fellowship) au Westchester Medical Center à New York
• Auteur de plus de 30 articles scientifiques et d'un chapitre de manuel
• Vaste expérience des troubles complexes de la moelle osseuse

Plus de 300 transplantations de moelle osseuse et de sang de cordon – Le Dr El Hasid dirige l'onco-hématologie pédiatrique à l'hôpital pour enfants Dana Dwek.

• Chef du département d'onco-hématologie et d'oncologie pédiatrique
• Membre de l'American Association for Hematology
• Publication de 50 articles de recherche dans le domaine
• Formation à l'hôpital City of Hope de Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Plus de 900 greffes de moelle osseuse réalisées – Le Dr Michael Shapira est un hématologue de premier plan au centre médical Sourasky.

• Se spécialiser en transplantation de moelle osseuse au centre médical Hadassah
• Être reconnu pour l'avancement de la médecine de transplantation
• Parler couramment l'anglais et l'hébreu
• Être diplômé de la faculté de médecine de l'Université hébraïque

Chef de l'Institut d'hématologie et de transplantation de moelle osseuse au centre médical Sourasky – Le Dr Aviv apporte son leadership et son expertise approfondie dans l'anémie aplasique.

• 31 ans de spécialisation en hématologie et oncologie
• Certifié par le conseil de l'ordre avec plusieurs adhésions à des sociétés professionnelles
• Se concentrer sur les syndromes myélodysplasiques et les transplantations

Directeur de l'oncologie hématologique pédiatrique au centre médical Sourasky – Le Dr Levin est spécialisé dans les troubles sanguins et le cancer des os chez l'enfant.

• Coordonner le traitement du sarcome avec le département d'oncologie-orthopédie
• Expert en hématologie pour les prématurés
• Formé à l'Institut orthopédique Rizzoli en Italie
• Membre de l'ISPHO – Association israélienne d'hémato-oncologie pédiatrique

Le Dr Kirshner participe à des recherches de pointe et à des essais cliniques sur l'anémie aplasique, notamment des essais de phase III au centre médical Sourasky.

• Formation spécialisée (Fellowship) en hématologie au Montefiore Medical Center
• Spécialisation dans les troubles sanguins rares comme l'anémie aplasique
• Plus de 30 ans d'expérience en hématologie et oncologie
• Recherche axée sur des protocoles de traitement innovants
• Membre (Fellow) de l'American Society of Hematology

Le Dr Herishanu Yair a reçu de nombreux prix pour ses contributions à l'hématologie, notamment le Young Investigator Research Prize et le Klitzberg Oncology Award.

• Se spécialiser dans la leucémie lymphoïde chronique et l'anémie aplasique
• Membre des associations israélienne et américaine d'hématologie
• Publier des recherches approfondies dans le domaine de l'hématologie
• Se former dans les meilleures institutions médicales d'Israël

Le Dr Irina Zaidman se spécialise en greffe de moelle osseuse pédiatrique – un traitement essentiel de l'anémie aplasique – au centre médical Hadassah.

• Fellowship en greffe de moelle osseuse pédiatrique au Hospital for Sick Children de Toronto
• Membre du conseil d'administration de la Société israélienne d'hémato-oncologie pédiatrique
• Membre des sociétés européenne et américaine de greffe de moelle osseuse
• Recherches publiées sur les greffes de moelle osseuse pédiatriques

Le Dr Spielberg est un onco-hématologue dévoué au centre médical Assuta, spécialisé dans les troubles sanguins tels que l'anémie aplasique.

• Se concentrer sur le diagnostic et la planification complète des traitements
• Être expert dans la gestion des syndromes d'insuffisance médullaire
• Travailler au plus grand hôpital privé d'Israël, le centre médical Assuta
• Fournir des soins personnalisés pour les affections hématologiques complexes

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Réalisation de plus de 3 500 greffes de moelle osseuse – reconnu par Forbes comme l'un des meilleurs médecins en 2018.

• 20 ans d'expérience en hématologie pédiatrique
• Spécialisé dans le traitement des enfants atteints de maladies du sang rares
• Connu par les patients comme « celui qui transplante la vie »
• Travaille au centre médical Hadassah